best oral tirzepatide LPT® Chewable Scored Tablets 1 and GIP mechanism in a daily Oral Tirzepatide: Dual-Incretin GLP-1 in

A comprehensive review on the Neuroprotective potential of resveratrol in ischemic stroke

Talk with a doctor or pharmacist if you have any questions

Phase 3 TRIUMPH trials ongoing as of 2026

Home Medical news & Guidelines Anesthesiology Cardiology and CTVS Critical Care Dentistry Dermatology Diabetes and Endocrinology ENT Gastroenterology Medicine Nephrology Neurology Obstretics-Gynaecology Oncology Ophthalmology Orthopaedics Pediatrics-Neonatology Psychiatry Pulmonology Radiology Surgery Urology Laboratory Medicine Diet Nursing Paramedical Physiotherapy Health news Fact Check Bone Health Fact Check Brain Health Fact Check Cancer Related Fact Check Child Care Fact Check Dental and oral health fact check Diabetes and metabolic health fact check Diet and Nutrition Fact Check Eye and ENT Care Fact Check Fitness fact check Gut health fact check Heart health fact check Kidney health fact check Medical education fact check Men's health fact check Respiratory fact check Skin and hair care fact check Vaccine and Immunization fact check Women's health fact check AYUSH State News Andaman and Nicobar Islands Andhra Pradesh Arunachal Pradesh Assam Bihar Chandigarh Chattisgarh Dadra and Nagar Haveli Daman and Diu Delhi Goa Gujarat Haryana Himachal Pradesh Jammu & Kashmir Jharkhand Karnataka Kerala Ladakh Lakshadweep Madhya Pradesh Maharashtra Manipur Meghalaya Mizoram Nagaland Odisha Puducherry Punjab Rajasthan Sikkim Tamil Nadu Telangana Tripura Uttar Pradesh Uttrakhand West Bengal Medical Education Industry Tirzepatide Shows Lower Mortality and Better Cardiorenal Outcomes than Semaglutide in Coronary Artery Disease and Obesity: AHJ Study, December 2025 In patients with coronary artery disease (CAD) and obesity, tirzepatide was associated with lower mortality and reduced cardiovascular and renal complications compared to semaglutide, suggesting differences in cardiorenal protection between these incretin-based therapies

The authors said they hope their findings spark additional research into how GLP-1RAs affect patients with RA